赢8娱乐糖果配对游戏-官方网站[welcome]


+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Drug treatment of functional dyspepsia



Drug treatment of functional dyspepsia



Scandinavian Journal of Gastroenterology. Supplement 182: 47-60



The therapeutic principles that have been applied to patients with peptic ulceration have often also been applied to those with functional dyspepsia, who by definition have no evidence of a structural or biochemical explanation for their symptoms. Treatments offered have included prokinetic drugs, anticholinergics, antacids, H2-receptor antagonists, selective muscarinic M1-receptor blockers, sucralfate, bismuth, antibiotics, and even surgery. The large range of therapies prescribed reflects the uncertainty about pathogenesis and the lack of a satisfactory treatment. Patients with functional dyspepsia should not be lumped into one broad category; treatment needs to be individualized. Certain subgroups of patients with functional dyspepsia may respond to some drug classes, whereas others may not be efficacious, although this remains to be established. The results of therapeutic studies are critically evaluated in this review.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 002076262

Download citation: RISBibTeXText

PMID: 1896830

DOI: 10.1097/00004836-198904000-00011


Related references

Drug Treatment of Functional Dyspepsia. Scandinavian Journal of Gastroenterology 26(s182): 47-60, 1991

Drug treatment of functional dyspepsia. World Journal of Gastroenterology 12(17): 2694-2700, 2006

Tu1430 Functional Dyspepsia Treatment Trial (Fdtt): Effect of Antidepressants on Mood Response in Functional Dyspepsia. Gastroenterology 148(4): S-889, 2015

Acotiamide (Z-338, YM443), a new drug for the treatment of functional dyspepsia. Expert Opinion on Investigational Drugs 20(5): 701-712, 2011

Electrogastrography associated with symptomatic changes after prokinetic drug treatment for functional dyspepsia. World Journal of Gastroenterology 18(41): 5948-5956, 2012

DA-9701: A New Multi-Acting Drug for the Treatment of Functional Dyspepsia. Biomolecules and Therapeutics 21(3): 181-189, 2013

DA-9701 (Motilitone): A Multi-Targeting Botanical Drug for the Treatment of Functional Dyspepsia. International Journal of Molecular Sciences 19(12):, 2018

Functional Dyspepsia Treatment Trial (FDTT): a double-blind, randomized, placebo-controlled trial of antidepressants in functional dyspepsia, evaluating symptoms, psychopathology, pathophysiology and pharmacogenetics. Contemporary Clinical Trials 33(3): 523-533, 2012

Drug treatment of functional dyspepsia. A meta-analysis of randomized controlled clinical trials. Journal of Clinical Gastroenterology 11(2): 169-177, 1989

Do dyspepsia subgroups predict response to treatment in functional dyspepsia?. Gastroenterology 114(4 Part 2): A154, 1998

Drug treatment of functional dyspepsia: a systematic analysis of trial methodology with recommendations for design of future trials. American Journal of Gastroenterology 91(4): 660-673, 1996

Stepwise diagnosis and treatment from uninvestigated dyspepsia to functional dyspepsia in clinical practice in Japan: proposal of a 4-step algorithm. Digestion 79(Suppl. 1): 19-25, 2009

Double-blind placebo-controlled multicentre studies of rebamipide, a gastroprotective drug, in the treatment of functional dyspepsia with or without Helicobacter pylori infection. Alimentary Pharmacology and Therapeutics 15(10): 1603-1611, 2001

Challenges in drug development for functional gastrointestinal disorders. Part I: functional dyspepsia. Neurogastroenterology and Motility 18(5): 346-353, 2006

Nomenclature of dyspepsia, dyspepsia subgroups and functional dyspepsia: clarifying the concepts. Bailliere's Clinical Gastroenterology 12(3): 417-433, 1998





赢8娱乐糖果配对游戏